A Phase I Clinical Trial of an HPV Therapeutic Vaccine
NCT01653249
·
clinicaltrials.gov ↗
PHASE1
Phase
COMPLETED
Status
52
Enrollment
OTHER
Sponsor class
Conditions
Human Papillomavirus
Interventions
BIOLOGICAL:
Vaccine consisting of four HPV-16 E6 peptides in combination with Candin®
Sponsor
University of Arkansas
Collaborators
[object Object]